Location History:
- Abingdon, GB (2008 - 2010)
- Oxfordshire, GB (2024)
Company Filing History:
Years Active: 2008-2025
Title: Oliver Philps: Innovator in Pharmaceutical Compounds
Introduction
Oliver Philps is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address disorders caused by IgE. With a total of 4 patents to his name, Philps has established himself as a key figure in innovation.
Latest Patents
Philps's latest patents include the development of tetrahydrobenzo-quinoline sulfonamides derivative compounds. This invention relates to tetrahydrobenzo-isoquinoline sulfonamides derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them, and their use in treating disorders caused by IgE, such as allergic responses and certain autoimmune responses. Another significant patent involves thiophene derivatives for the treatment of disorders caused by IgE. These compounds, along with their pharmaceutically acceptable salts, are designed to treat or prevent disorders such as allergies and type 1 hypersensitivity.
Career Highlights
Throughout his career, Philps has worked with prominent companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and UCB Biopharma. His work has contributed to advancements in treatments for various medical conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Philps has collaborated with notable professionals in his field, including Gregory William Haslett and Timothy John Norman. These partnerships have further enhanced his research and development efforts.
Conclusion
Oliver Philps is a distinguished inventor whose work in pharmaceutical compounds has made a significant impact on the treatment of IgE-related disorders. His innovative patents and collaborations reflect his commitment to advancing medical science.